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Summary
 
We explored expression and possible function of interferon-
 
g
 
 (IFN-
 
g
 
) in cultured fetal (E15)
rat dorsal root ganglion neurons combining whole cell patch-clamp electrophysiology with sin-
gle cell reverse transcriptase polymerase chain reaction and confocal laser immunocytochemis-
try. Morphologically, we located IFN-
 
g
 
 protein in the cytoplasm of the neurons in culture as
well as in situ during peri- and postnatal development. Transcripts for classic IFN-
 
g
 
 and for its
receptor were determined in probes of cytoplasm sampled from individual cultured neurons,
which had been identified by patch clamp electrophysiology. In addition, the cultured neurons
expressed both chains of the IFN-
 
g
 
 receptor.
Locally produced IFN-
 
g
 
 acts back on its cellular source. Phosphorylation and nuclear trans-
location of the IFN-inducible transcriptional factor STAT1 as well as IFN-
 
g
 
–dependent ex-
pression of major histocompatibility complex class I molecules on the neuronal membrane
were noted in untreated cultures. However, both processes were substantially blocked in the
presence of antibodies neutralizing IFN-
 
g
 
. Our findings indicate a role of IFN-
 
g
 
 in autocrine
regulation of sensory neurons.
 
I
 
nterferon-
 
g
 
 (IFN-
 
g
 
), or “immune interferon”, is a key
mediator required to correctly orchestrate antimicrobial
and inflammatory tissue responses. It is remarkably pleio-
tropic, evoking highly diverse effects in many if not all tis-
sues. The cytokine affects proliferation, differentiation, and
the ability to communicate in individual cells. In particular,
IFN-
 
g
 
 controls the expression of genes encoding molecules
required in immune reactions, such as MHC products, cell
adhesion molecules, cytokines, and cytocidal proteins. In
contrast to IFN-
 
g
 
’s global activities, the cellular sources of
the cytokine are remarkably restricted, with certain sets of
activated T lymphocytes and NK cells as the sole known
producers (1, 2).
However, IFN-
 
g
 
 is not limited to the immune re-
sponses. In addition to its proinflammatory function, some
evidence suggests that IFN-
 
g
 
 may also affect differentiation
and survival of neuronal cells. For example, in one investi-
gation the cytokine delayed degeneration of sympathetic
neurons caused by withdrawal of nerve growth factor (3).
Furthermore, in the pheochromocytoma cell line PC12,
IFN-
 
g
 
 facilitated nerve growth factor–induced neuronal
differentiation (4) and induced long-term excitability by
activating transcription of the peripheral nerve type 1 so-
dium channel (5). Finally, the cytokine promoted cholin-
ergic differentiation of neurons derived from embryonic
septal nuclei (6).
Thus far, the cellular source of IFN-
 
g
 
 in healthy nervous
tissue has not been determined. Several reports described
IFN-
 
g
 
–like immunoreactivity in dorsal root ganglia (7, 8),
and an “IFN-
 
g
 
–like protein” extracted from sensory tri-
geminal rat ganglia was shown to share some biological ac-
tivity with lymphocyte-derived IFN-
 
g
 
 (9). However, the
molecular nature of these structures remained elusive. At-
tempts to identify mRNA for the cytokine were inconclu-
sive (10), and the molecular weight of the “IFN-
 
g
 
–like acti-
vity” differed substantially from that of the classic cytokine.
In this study, we characterized IFN-
 
g
 
 gene transcripts in
cultured fetal rat dorsal root ganglion (DRG)
 
1
 
 neurons
combining patch-clamp electrophysiology with single cell
reverse transcriptase (RT)–PCR amplification. We dem-
onstrate that IFN-
 
g
 
 immunoreactivity in the cytoplasm of
cultured DRG neurons is indeed associated with the tran-
scription of mRNA for classic IFN-
 
g
 
. We also present
functional evidence of autocrine/paracrine regulatory ac-
tivity exerted by neuronal IFN-
 
g
 
.
 
1
 
Abbreviations used in this paper:
 
 DRG, dorsal root ganglion; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; GFAP, glial fibrillary acidic
protein; RT, reverse transcriptase.
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Material and Methods
 
Cell Culture.
 
DRG were prepared from Wistar rat fetuses
(E15) obtained from the breeding facility (Max-Planck-Institute
for Psychiatry) as previously described (11). In brief, DRG were
removed from the fetuses and were dissociated by 0.1% trypsin
(Worthington Biochemical Corporation, Freehold, NJ). Cells
were dissociated by trituration and were cultured on poly-
 
l
 
-orni-
thine (0.1 mg/ml, Sigma Chemical Co., Taufkirchen, Germany)
plus laminin-coated (10 
 
m
 
g/ml, gift from Dr. Ries, Max-Planck-
Institute for Biochemistry, Martinsried, Germany) dishes in
DMEM medium (GIBCO BRL, Eggenstein, Germany) supple-
mented with 10% fetal calf serum (Pansystems GmbH, Nürnberg,
Germany) and 10 ng/ml nerve growth factor (NGF-7S mouse,
Sigma Chemical Co.). On the first day cells were treated for 24 h
with 10 
 
m
 
M 5-fluoro-2-deoxyuridine (Sigma Chemical Co.) and
10 
 
m
 
M uridine (Sigma Chemical Co.) to inhibit growth of non-
neuronal cells. Antibodies neutralizing IFN-
 
g
 
 (30 
 
m
 
g/ml, DB1;
Laboserv, Gießen, Germany) were added to the cell culture as
described in the text. Hippocampal cell cultures (12) and T cell
cultures (13) were performed as previously described.
 
Patch-clamp RT-PCR.
 
Whole cell recording and reverse tran-
scription of cytoplasmic RNA from single neurons was per-
formed as previously described (14). Cytoplasmic RNA of indi-
vidual CD4
 
1
 
 myelin basic protein-specific T lymphoblasts (13)
and of satellite cells from the DRG culture was collected with the
patch-clamp pipette and was reverse transcribed using the same
protocol as previously described (14). Oligonucleotides for PCR
amplification were selected with program PRIMER (Whitehead
Institute, Cambridge, MA) and were produced by the Max-Planck-
Institute for Biochemistry (Martinsried, Germany). Forward primer
and reverse primer were always chosen from different exons to
detect possible amplification of genomic DNA contamination.
The primer sequences were as follows: for rat IFN-
 
g
 
 (These se-
quence data are available from EMBL/GenBank/DDBJ under
accession numbers X02326 and X02327), 5
 
9
 
-AGGATGCAT-
TCATGAGCATCGCC-3
 
9
 
 (385–407) and 5
 
9
 
-CACCGACTC-
CTTTTCCGCTTCCT-3
 
9
 
 (223–201); and for rat CD4 (W3/25;
accession number M15768), 5
 
9
 
-GTGCCGAGGCTTCTCTT-
TCAGG-3
 
9
 
 (56–77) and 5
 
9
 
-CCCAGAATTGTCTTTTGGT-
CAGAGG-3
 
9
 
 (247–273). The primer sequences for glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), glial fibrillary acidic
protein (GFAP), and IFN-
 
g
 
–receptor have been previously de-
scribed (14). PCR-amplification was done in a final volume of 50 
 
m
 
l
containing 1 
 
m
 
l of transcribed cDNA probe, the four deoxyribo-
nucleotide triphosphates (final 0.2 mM, Pharmacia), 2.5 U Ampli-
Figure 1. IFN-g immunore-
activity in the DRG during post-
natal development. (A) Frozen
section from rat postnatal day 9
DRG was immunolabeled with
antibodies directed against IFN-g.
The IFN-g immunoreactivity
was detectable in the DRG, but
not in the adjacent muscle tissue.
Scale bar: 50 mm. (B) The
perikarya and processes of a sub-
population of neurons were im-
munolabeled with IFN-g–spe-
cific antibodies in a frozen
section of postnatal day 9 DRG.
Scale bar: 20 mm. 
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Taq (Perkin-Elmer/Applied Biosystems GmbH, Weiterstadt, Ger-
many) and 1
 
3
 
 PCR-buffer (Perkin-Elmer/Applied Biosystems
GmbH) covered with two drops of mineral oil (Sigma Chemical
Co.). Before PCR amplification on a programmable thermocy-
cler (MultiCycler PTC 200, MJ Research Inc.), denaturated prim-
ers (final 100 pmol primers) were added to each tube at 80
 
8
 
C.
The cDNA was denaturated at 95
 
8
 
C for 3 min. PCR was per-
formed on cDNA from single cells with 48–50 cycles (93
 
8
 
C for
60 s; ramp with 0.1
 
8
 
C/s from 93
 
8
 
C to 60
 
8
 
C; 60
 
8
 
C for 60 s; 72
 
8
 
C
for 60 s) and followed by one final cycle at 72
 
8
 
C for 5 min. 10 
 
m
 
l
of the amplified fragments was run along with the molecular
weight marker (
 
F
 
X 174, HaeIII digested; Pharmacia Biotech,
Freiburg, Germany) on a 1.7% agarose gel electrophoresis stained
with ethidium bromide. For Southern blot analysis the DNA
fragments of the gel were transferred onto a nylon membrane
(Hybond N
 
1
 
, Amersham Buchler, Braunschweig, Germany).
The resulting blot was hybridized with a rat IFN-
 
g
 
–specific
probe (rat IFN-
 
g
 
; these sequence data are available from EMBL/
GenBank/DDBJ under accession number X02327: 130–153) us-
ing the Digoseigenin Southern blot Hybridization System (Boeh-
ringer Mannheim, Mannheim, Germany) according to the manu-
facturer’s instructions. For sequencing, the PCR fragments were
gel-purified (QIAGEN, Hilden, Germany) and were sequenced by
MediGene (Martinsried, Germany) with an automated sequence
analyzer.
 
Immunofluorescence Labeling and Confocal Laser Scanning Microscopy.
 
Cultured rat DRG neurons or frozen sections of rat lumbar DRG
were fixed with 4% paraformaldehyde in PBS. For labeling of
MHC class I molecules on the cell membrane, mouse mono-
clonal antibodies directed against MHC class I (Ox 18, 10 
 
m
 
g/ml;
Serotec Ltd., Oxford, England) were added to the cell culture for
60 min before fixation. Nonspecific binding sites were blocked
with PBS containing 2% goat serum and 2% bovine albumin. For
intracellular labeling, cultured cells were treated with PBS con-
Figure 2. IFN-g immunore-
activity in cultured sensory neu-
rons. (A) IFN-g immunofluores-
cence labeling in neurons.
Embryonic sensory neurons cul-
tured for 7 d were identified by
antibodies recognizing neurofila-
ment and were double-labeled
with antibodies directed against
IFN-g. Scale bar: 10 mm. (B)
Confocal laser scanning micros-
copy of sensory neurons. Neu-
rofilament labeling is located in
the cytoplasm and the neuronal
processes, whereas IFN-g label-
ing is only localized in the peri-
nuclear cytoplasm. Scale bar: 10
mm. (C) Incubation with pri-
mary control antibodies instead
of IFN-g–specific antibodies
showed baseline labeling inten-
sity. Scale bar: 10 mm. 
2026
 
Interferon-
 
g
 
 in Sensory Neurons
taining 0.1% Triton X-100 for 30 min. In the first step, cells or
tissue sections were labeled with mouse monoclonal antibodies
recognizing rat IFN-
 
g
 
 (DB1; 10 
 
m
 
g/ml), mouse monoclonal an-
tibodies directed against STAT1 (5 
 
m
 
g/ml; PharMingen, Hamburg,
Germany), rabbit polyclonal antibodies recognizing an epitope of
IFN-
 
g
 
–receptor 
 
a
 
 chain corresponding to amino acids 461–477
(2 
 
m
 
g/ml, K-17; Santa Cruz Biotechnology, Heidelberg, Ger-
many), or rabbit polyclonal antibodies recognizing an epitope of
IFN-
 
g
 
–receptor 
 
b
 
 chain corresponding to amino acids 312–331
(2 
 
m
 
g/ml, M-20; Santa Cruz Biotechnology) followed by sec-
ondary fluorochrome Cy3–conjugated goat antibodies directed
against mouse or rabbit immunoglobulin (10 
 
m
 
g/ml; Dianova,
Hamburg, Germany). In a second step, cells were double-labeled
with mouse monoclonal antibodies recognizing neurofilament (2
 
m
 
g/ml, NN18; Boehringer Mannheim) followed by fluorochrome
(dichlorotriazinyl) aminofluorescein–conjugated antibodies to mouse
immunoglobulin (5 
 
m
 
g/ml; Dianova, Hamburg, Germany). Con-
ventional photographs were taken with an immunofluorescence
microscope (Carl Zeiss, Oberkochen, Germany). Confocal im-
ages were acquired with a confocal laser scanning microscope
(Leica, Bensheim, Germany) equipped with 
 
3
 
63 oil objectives.
Baseline labeling for the IFN-
 
g
 
, STAT1, and MHC class I stain-
ing procedures was revealed with irrelevant mouse monoclonal
antibodies (10 
 
m
 
g/ml; Dianova) and secondary fluorochrome
Cy3–conjugated goat antibodies to mouse immunoglobulin (10
 
m
 
g/ml; Dianova). Baseline labeling for the IFN-
 
g
 
–receptor 
 
a
 
 and
 
b
 
 chains was revealed by adding the corresponding (blocking)
peptides (2 
 
m
 
g/ml; Santa Cruz Biotechnology) to the polyclonal
rabbit antibodies, followed by secondary fluorochrome Cy3–con-
 
jugated goat antibodies to rabbit immunoglobulin (10 
 
mg/ml; Di-
anova).
Statistical Analyses. Data were determined by three indepen-
dent experiments and are indicated as mean 6 SEM. Analyses of
STAT1 as well as of MHC class I by confocal laser scanning mi-
croscopy revealed significant (P ,0.01) difference between the
untreated and IFN-g neutralizing antibody–treated group in the
unpaired two-tail Student’s t test.
Results
IFN-g Expression in Sensory Neurons. Histological sections
were performed from rat lumbar DRG tissue. IFN-g im-
munolabeling was detectable in a subpopulation of DRG
cells during peri- and postnatal development (Fig. 1). His-
tological sections showed strong IFN-g expression at em-
bryonic day 18 and during the first 2 wk after birth. The in
situ IFN-g labeling was very prominent in the neuronal
perikarya, but was also demonstrable in the neuronal pro-
cesses (Fig. 1).
DRG cells from embryonic rats (E15) were cultured in
the presence of nerve growth factor. Most of the DRG
neurons that differentiated in vitro bound monoclonal anti-
bodies recognizing IFN-g. Specific immunofluorescence
Figure 3. Identification of neurons by whole cell patch-clamp electro-
physiology. (A) Action potentials were evoked in sensory neurons cul-
tured for 7 d by current pulses of increasing amplitude (200, 300, and 400
pA) and were recorded in the current clamp mode. (B) Whole cell mem-
brane currents were evoked by successive depolarization steps of 10 mV
(from a holding potential of 280 mV to voltages ranging from 250 to
150 mV) and were recorded in the voltage clamp mode. Figure 4. Single cell RT-PCR of CD41 T lymphoblasts and DRG sat-
ellite cells. Gene transcripts for GAPDH (A), GFAP (B), CD4 (C), and
IFN-g (D) were analyzed by single-cell RT-PCR of activated T cells
(lanes 1–3) and of DRG satellite cells (lanes 4–6). N and M show negative
PCR control and molecular weight marker, respectively.2027 Neumann et al.
was detected after 7 d in culture in 83 6 8% of DRG neu-
rons identified by neurofilament labeling, but in none of
the nonneuronal cells (Fig. 2). Confocal laser scanning mi-
croscopy localized the IFN-g proteins in the cytoplasm,
sparing the nucleus and the cell membrane (Fig. 2), whereas
processes and dendrites showed no or only very weak reac-
tivity.
IFN-g Gene Transcription in Sensory Neurons. After 7 d
in culture, neurons could be distinguished morphologically
from nonneuronal cells. Their neuronal identity was ascer-
tained by whole cell patch-clamp electrophysiology (15). As
expected, the DRG-derived neurons showed sodium cur-
rents activated at different membrane potentials, and re-
sponded to current pulses of increasing amplitude with so-
dium action potentials (Fig. 3).
We then used single-cell RT-PCR analysis to identify the
intraneuronal IFN-g–like material. After electrophysiologi-
cal characterization, we sampled cytoplasmic specimens from
individual neurons through the patch-clamp micropipette,
and assessed current gene transcription by RT-PCR. Oli-
gonucleotides specific for IFN-g were used to amplify gene
transcripts for the cytokine. In addition, as in our previous
studies, coamplification of mRNA for the house-keeping
enzyme GAPDH and for cell lineage markers served as in-
ternal quality standards (12, 14). The validity of our method
was corroborated by parallel analyses of activated CD41 T
lymphocytes with a Th1-like phenotype (13) and DRG-
derived glia cells (Fig. 4). Each single T lymphoblast ana-
lyzed contained mRNA for the lineage marker gene CD4
along with IFN-g. In contrast, satellite cells from DRG cul-
tures, which expressed glia specific GFAP gene transcripts,
and were negative for IFN-g and CD4 gene transcripts
(Fig. 4). In a subsequent cytokine study of 19 individual
DRG neurons, mRNA for IFN-g was identified in 13 cells
cultured for 7 d (Fig. 5). Southern blot analysis and se-
quencing confirmed the identity of the amplified fragments
with classic IFN-g. IFN-g gene expression in cultured DRG
neurons developed steadily over time. Among neurons cul-
tured for 2 h, only a minority (1/11) of the (electrophysio-
logically immature) cells expressed IFN-g gene transcripts
(Fig. 5). However, the percentage of IFN-g–expressing
neurons continuously increased through the first 24 h in
culture. After 6 h, 3/13 neurons, and after 24 h, 7/11 DRG
neurons, expressed IFN-g gene transcripts. In contrast, dif-
ferentiated neurons derived from hippocampus tissue tran-
scribed IFN-g at no time.
IFN-g–receptor Expression of Sensory Neurons. IFN-g acts
on its target cells by binding to and activating membrane-
bound IFN-g receptors, heterodimeric proteins composed
by a cytokine-binding a chain and signal-transducing b
chain (16). Gene transcripts for the IFN-g receptor a
chains were detected in all DRG neurons analyzed (Fig. 6)
Figure 5. Gene transcripts for IFN-g detected in sensory neurons by
single-cell RT-PCR. (A) IFN-g gene transcripts amplified from individ-
ual neurons. Embryonic sensory neurons were cultured for 7 d and were
identified by electrophysiology. Gene transcripts for GAPDH (lanes 1–9)
and IFN-g (lanes 1, 3, 4, 6–9) were detected by single-cell RT-PCR in
individual neurons. N and M show negative PCR control and molecular
weight marker, respectively. (B) Frequency of DRG neurons transcribing
IFN-g in relation to time in culture.
Figure 6. IFN-g receptor gene transcripts in sensory neurons. Gene
transcripts for GAPDH (lanes 1–5) and IFN-g–receptor a chain (lanes 1–5)
were amplified from single neurons by RT-PCR. N and M show nega-
tive PCR control and molecular weight marker, respectively.2028 Interferon-g in Sensory Neurons
Membrane expression of the receptor complex was con-
firmed by immunofluorescence and confocal laser scanning
microscopy. IFN-g–receptor a chain–specific antibodies
labeled 98 6 4% of neurofilament-positive DRG neurons,
predominantly on the cell membrane (Fig. 7). The signal-
transducing b chain was detected on 97 6 5% sensory neu-
rons (Fig. 7). Simultaneous expression of a cytokine along
with its specific receptor in the same cell provides a neces-
sary, although insufficient, structural basis for autocrine
regulation. This is the proven case in IFN-g production by
activated T lymphocytes (17), and could also hold true for
our cultured DRG neurons. Since the binding of IFN-g to
its receptors results in phosphorylation and translocation of
the transcriptional factor STAT1 from the cytoplasm to the
nucleus (16), both features of STAT1 activation should be
demonstrable in the cells of our DRG cultures, and should
be reversed by the addition of neutralizing antibodies
against IFN-g.
Autocrine Activation of STAT1 and MHC class I in Sensory
Neurons. Western blot analysis of total cell lysate of DRG
cultures demonstrated phosphorylated STAT1 (data not
shown), but this method does not identify the cell type in
the mixed DRG culture that has the active form of STAT1.
However, confocal laser scanning microscopy clearly lo-
cated STAT1 in the nuclei of almost all cultured neurofila-
ment-positive DRG neurons (96 6 4%, Figs. 8 and 9), and
also in the glia cells. In contrast, in differentiated hippo-
campal neuronal cultures, where no IFN-g synthesis is de-
monstrable, all STAT1 immunoreactivity was confined to
the cytoplasm (Fig. 8). IFN-g–neutralizing antibodies to
DRG cultures profoundly interfered with nuclear translo-
cation of STAT1. After neutralization of IFN-g, most neu-
rons displayed STAT1 within their cytoplasm, with nuclear
location seen only in a minority of all cells (26 6 11%,
Figs. 8 and 9).
The possible auto/paracrine action of neuronal IFN-g
was supported by an investigation of MHC class I expres-
sion on cultured DRG neurons. As previously reported,
IFN-g readily induces MHC class I genes in electrically si-
lent neurons, but much less so in firing neurons (12, 14).
Adult sensory DRG neurons are silent in culture, and are
susceptible to MHC class I induction by IFN-g (18). Thus,
in the case of autocrine activity of neuronal IFN-g, cul-
tured IFN-g–secreting neurons should constitutively ex-
press MHC class I on their membranes. That this is the case
was documented by confocal microscopy with MHC class I
expression on 67 6 11% of all sensory neurons (cultured
for 5 d and identified by a neurofilament marker, Figs. 8
and 9). Treatment of the DRG culture with neutralizing
anti–IFN-g monoclonal antibodies reduced the proportion
of MHC class I–positive neurons to 14 6 3% (Fig. 9).
Discussion
Over the past few years it has become clear that numer-
ous humoral mediators that originally had been thought to
Figure 7. IFN-g receptor ex-
pression detected on sensory
neurons by confocal laser scan-
ning microscopy. (A) Confocal
localization of IFN-g receptor (a
chain) of sensory neurons. Em-
bryonic sensory neurons (cul-
tured for 2 d) were identified by
antibodies recognizing neurofila-
ment and were double labeled
with antibodies directed against
IFN-g–receptor  a chain. (B)
Immunolabeling of IFN-g re-
ceptor (b chain) on the neuronal
cell membrane. Sensory neurons
(cultured for 2 d) were identified
by double-labeling with neu-
rofilament. Scale bar A and B:
10  mm.2029 Neumann et al.
act exclusively either in the immune system or in the ner-
vous system in fact interconnect both organ systems. For
example, neurotrophic factors like nerve growth factor are
not restricted to neural cells, but are produced by and act
on immune cells as well (19). Conversely, a number of cy-
tokines with classical immune functions are also effective in
nervous tissues. Proinflammatory cytokines like TNF-a or
IL-1 influence neuronal function and behavior (20). A pro-
Figure 8. Nuclear localiza-
tion of STAT1 and cell mem-
brane expression of MHC class I
molecules. (A) Nuclear localiza-
tion of STAT1 in sensory neu-
rons. Embryonic sensory neu-
rons were cultured for 2 d and
analyzed by confocal laser scan-
ning microscopy for neurofila-
ment and STAT1. (B) Cytoplas-
mic localization of STAT1 in
neurons of hippocampal cultures.
(C) Cytoplasmic localization of
STAT1 in sensory neurons (cul-
tured for 2 d) in the presence of
neutralizing antibodies directed
against IFN-g. (D) MHC class I
molecules detected on the cell
membrane of untreated sensory
neurons. Sensory neurons (cul-
tured for 5 d) were identified by
antibodies recognizing neurofila-
ment and were immunolabeled
with antibodies directed against
MHC class I on the cell surface.
Scale bar A, B, C, and D: 10 mm.2030 Interferon-g in Sensory Neurons
portion of these mediators may be imported through the
blood brain barrier or discharged in the central nervous sys-
tem by immigrant inflammatory cells. But it has also be-
come clear that many of these cytokines are produced and
released within the nervous system by autochthonous cells
(21, 22). In this study, we have shown that classical IFN-g
is produced and used by neurons in the peripheral nervous
system.
Autocrine gene regulation is a common feature of the
cytokine network. For example, IFN-g produced by sub-
sets of activated T cells activates STAT1 factor and thereby
upregulates its own gene expression (17, 23). Likewise, in
the brain, neurotrophils such as brain-derived neurotrophic
factor prevent death of adult sensory neurons acting in au-
tocrine loops (24). Our results now suggest that STAT1 ac-
tivation in neurons is at least partially regulated by IFN-g pro-
duced by the same cells. Although neutralization of IFN-g
by monoclonal antibodies suppressed MHC class I mem-
brane expression on neurons almost completely, this proce-
dure inhibited phosphorylation and translocation of STAT1
only partially. This can be explained by the activity of neu-
ral mediators ligating the gp130 receptor of the IL-6/CNTF
family of cytokines, which uses besides STAT3 also the
STAT1 activation pathway (25).
Most reports on IFN-g activity within the nervous sys-
tem are related to inflammatory responses, as represented
by experimental autoimmune encephalomyelitis, multiple
sclerosis, or microbial brain infections. In these situations,
the cytokine is mainly produced and released by infiltrating
immune cells (26). This is in contrast to neuronal IFN-g,
whose particular temporal and spatial expression patterns
suggest a developmental function, possibly related to the
differentiation of peripheral nerves.
Autocrine IFN-g secretion by DRG neurons may con-
tribute signals controlling neuronal differentiation (4), like
activation of neuron-specific genes encoding the peripheral
nerve type 1 sodium channel (5). Other possible targets of
IFN-g–dependent regulation are the genes controlling neu-
ron transmitter production (6). Alternatively, DRG neuronal
IFN-g could regulate glia cells surrounding the neurons in
situ. In vitro, IFN-g interferes with myelination of central
nervous system (27) and peripheral nerve myelination (28).
In agreement with this, transgenic mice constitutively pro-
ducing IFN-g in their central nervous system display a
“tremoring” phenotype coinciding with a “dramatic over-
all decrease in central nervous system myelin” (29).
Demonstration of local production of IFN-g by small
and medium sized DRG neurons (which are enriched in
our nerve growth factor–dependent culture model) and its
auto/paracrine action on local cells predicts a new and un-
expected function of this unusually pleiotropic proinflam-
matory cytokine.
Figure 9. Autocrine activation of STAT1 and MHC class I in sensory
neurons. (A) Frequency of sensory neurons (cultured for 2 d with or
without IFN-g neutralizing antibodies) demonstrating the nuclear local-
ization of STAT1. (B) MHC class I molecules on the cell membrane of
sensory neurons (cultured for 5 d) untreated or treated with IFN-g neu-
tralizing antibodies.
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